FY26 Full Year Results Presentation
Filed with ASX · · 30 pages · English
In the deck
Story so far
Earlier from Aroa Biosurgery
- FY26 Appendix 4E and Full Year Results
- ARX FY26 Preliminary Results
- Symphony Randomised Control Trial Complete
- AROA Business Update Presentation
- AROA Business Update
Later from Aroa Biosurgery
- Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
- Symphony Significantly Improves DFU Healing
- Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery